J Infect Dis. 1992 Apr;165(4):695-701.

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group.

[No authors listed]

Abstract

To evaluate the efficacy of anti-J5 serum in the treatment of severe infectious purpura, 73 children were randomized to receive either anti-J5 (40) or control (33) plasma. Age, blood pressure, and biologic risk factors were similar in both groups. At admission, however, tumor necrosis factor serum concentrations were 974 +/- 173 pg/ml compared with 473 +/- 85 pg/ml (P = .023) and interleukin-6 serum concentrations were 129 +/- 45 compared with 19 +/- 5 ng/ml (P = .005) in the control and treated groups, respectively. The duration of shock and the occurrence of complications were similar in both groups. The mortality rate was 36% in the control group and 25% in the treated group (P = .317; odds ratio, 0.76; 95% confidence interval, 0.46-1.26). This trend disappeared after correction for unbalances in risk factors at randomization using a logistic regression model. These results suggest that anti-j5 plasma did not affect the course or mortality of severe infectious purpura in children.

PMID:: 1552198; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Bacterial Infections - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. [JAMA. 1997]
p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, et al. JAMA. 1997 May 21; 277(19):1531-8.
Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. [Crit Care Med. 2003]
Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA. Crit Care Med. 2003 Jun; 31(6):1839-47.
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. [J Infect Dis. 1988]
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
Calandra T, Glauser MP, Schellekens J, Verhoef J. J Infect Dis. 1988 Aug; 158(2):312-9.
Review Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. [Pediatr Allergy Immunol. 2004]
Review Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S. Pediatr Allergy Immunol. 2004 Jun; 15 Suppl 16:4-5, 9-32.
Review Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient. [Rev Infect Dis. 1987]
Review Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient.
Baumgartner JD, Glauser MP. Rev Infect Dis. 1987 Jan-Feb; 9(1):194-205.

See reviews... See all...

Cited by 6 PubMed Central articles

A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia. [Infect Immun. 2008]
A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia.
Jemmett K, Macagno A, Molteni M, Heckels JE, Rossetti C, Christodoulides M. Infect Immun. 2008 Jul; 76(7):3156-63. Epub 2008 Apr 28.
Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. [Crit Care. 2005]
Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.
Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, et al. Crit Care. 2005 Aug; 9(4):R331-43. Epub 2005 May 17.
Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS). [Clin Exp Immunol. 2000]
Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS).
Uronen H, Williams AJ, Dixon G, Andersen SR, Van Der Ley P, Van Deuren M, Callard RE, Klein N. Clin Exp Immunol. 2000 Dec; 122(3):312-5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of severe infectious purpura in children with human plasma from donors...
Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group.
J Infect Dis. 1992 Apr ;165(4):695-701.

PubMed
How does blood glucose control with insulin save lives in intensive care?
How does blood glucose control with insulin save lives in intensive care?
J Clin Invest. 2004 Nov ;114(9):1187-95.

PubMed
The electroencephalogram in sepsis-associated encephalopathy.
The electroencephalogram in sepsis-associated encephalopathy.
J Clin Neurophysiol. 1992 Jan ;9(1):145-52.

PubMed
Severity scoring in community-acquired pneumonia caused by Streptococcus pneumon...
Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Int J Antimicrob Agents. 2004 Nov ;24(5):485-90.

PubMed
Calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are eleva...
Calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma and decreased in vena cava during endotoxin shock in the rat.
Circ Shock. 1992 Jan ;36(1):21-30.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information